Safety of pain therapy during pregnancy and lactation in patients with inflammatory arthritis: A systematic literature review

Journal of Rheumatology

Volumn 39, Issue SUPPL. 90, 2012, Pages 59-61

  Adams, Karen ^a   Bombardier, Claire ^b,c,d   Van Der Heijde, Désirée M ^e  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Inflammatory arthritis; Lactation; Pain therapy; Pregnancy

Indexed keywords

IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; ANALGESIC AGENT;

ADOLESCENT; ADULT; ANALGESIA; ARTHRITIS; CONTROLLED STUDY; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; INFLAMMATORY ARTHRITIS; LACTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PAIN; PERINATAL DRUG EXPOSURE; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DRUG EFFECT; EMBRYO DEVELOPMENT; ENVIRONMENTAL EXPOSURE; FETUS DEVELOPMENT; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; EMBRYONIC DEVELOPMENT; FEMALE; FETAL DEVELOPMENT; HEART DEFECTS, CONGENITAL; HUMANS; LACTATION; MATERNAL EXPOSURE; PAIN; PAIN MANAGEMENT; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 84865845901     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration; 2009. Available from www.cochrane-handbook.org
2. Whittle SL, Colebatch AN, Buchbinder R, Edwards CJ, Adams K, Englbrecht M, et al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: Integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology 2012 Mar 24; [Epub ahead of print]
3. Sackett DL, Richardson WS, Rosenberg WM, Haynes RB. Evidence-based medicine: How to practice and teach EBM. London, UK: Churchill Livingstone; 1997.
4. Oxford Centre for Evidence-based Medicine - Levels of Evidence. March 2009. Oxford, UK: Centre for Evidence Based Medicine. Available from: http://www.cebm.net/index.aspx?o=1025
5. Martinez-Lopez JA. Systematic review: Is the use of NSAIDs safe during pregnancy in women with rheumatic disease? Rheumatol Clin 2008;4:191-6.
6. Østensen M, Matheson I, Laufen H. Piroxicam in breast milk after long-term treatment. Eur J Clin Pharmacol 1988;35:567-9.
7. Ericson A, Källén BAJ. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 2001;15:371-5.
8. Østensen M, Østensen H. Safety of nonsteroidal anti-inflammatory drugs in pregnant patients with rheumatic disease. J Rheumatol 1996;23:1045-9.
9. Lewis R, Schulman JD. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 1973;24:1159-61.